Axolabs Kulmbach Management

Dr Ingo Röhl

Managing Director Operations


Ingo started his career as Research Associate at the Riedel de Haën AG. He then studied Chemistry and, after completion of his Ph.D. at the University of Oldenburg, worked as Scientist at the Noxxon Pharma AG. 
Ingo joined Alnyam Europe AG in 2003 where he served as Head of Analytics and built up the analytical department. He held a position as Associate Director at the Roche Kulmbach GmbH and as Senior Director Analytics and Bioanalytics at the Axolabs Kulmbach GmbH. 
Ingo has more than 20 years of experience in the field of RNA drug development and (bio-) analytics. He has published more than 20 peer-reviewed articles and book chapters and is inventor on more than 10 patent applications. 


Friedrich Sanders

Managing Director Finance 


After working as a trainee with Deutsche Bank, Friedrich graduated with a degree in business administration from the University of Passau in Germany. He then worked for Diehl Group and was in charge of finance and controlling. Friedrich later served as CEO and CFO in a number of producing and servicing companies, gaining comprehensive experience in performance management and cultural development. 


Dr Philipp Hadwiger

Managing Director Research 


Philipp studied Chemistry at the Technical University of Graz, Austria. After earning his doctoral degree, he started his industry career in 2000 at Ribopharma AG and held positions of increasing responsibility at Alnylam Europe AG. After Roche’s acquisition of Alnylam’s European site, Philipp served as Director of Chemistry at Roche’s Centre of Excellence for RNA Therapeutics and was promoted to Senior Director of Chemistry at Axolabs. Philipp has published 40 peer-reviewed articles and is a named inventor on more than 20 patents.